TABLE 2.
Factor | Predictive Marginal (%)b | 95% CI | Wald Pc | |
---|---|---|---|---|
Age at last cancer diagnosis, y | ≤39 | 43.4 | 36.9–50.2 | <.0001 |
40–64 | 39.8 | 35.8–44.0 | ||
≥65 | 21.7 | 17.9–26.0 | ||
Sex | Male | 36.1 | 31.8–40.7 | .58 |
Female | 34.5 | 30.9–38.3 | ||
Marital status | Married or living with partner | 35.8 | 32.0–39.8 | .53 |
Never married/widowed/divorced/separated | 34.1 | 30.3–38.1 | ||
Race/ethnicity | Non-Hispanic white | 33.1 | 29.9–36.5 | 0.006 |
Non-Hispanic black | 46.6 | 38.4–55.0 | ||
Hispanic | 42.1 | 32.2–52.7 | ||
Other | 46.1 | 30.8–62.1 | ||
Education | <High school | 40.2 | 33.3–47.6 | .17 |
High school or GED | 37.3 | 32.2–42.7 | ||
Some college+ | 33.0 | 29.2–37.1 | ||
Insurance paid for all or part of cancer treatment | Yes | 34.8 | 31.7–38.1 | .51 |
No/unknown | 37.5 | 30.4–45.1 | ||
Region | Northeast | 29.3 | 24.4–34.8 | .09 |
Midwest | 36.2 | 30.0–42.8 | ||
South | 38.7 | 33.5–44.2 | ||
West | 32.8 | 27.6–38.5 | ||
Recurrence/multiple cancers | Yes | 40.9 | 34.4–47.7 | .049 |
No | 33.7 | 30.6–37.0 | ||
Y since last cancer diagnosis | <2 | 45.2 | 37.4–53.2 | <.0001 |
2–5 | 40.0 | 34.9–45.4 | ||
6–9 | 34.7 | 28.4–41.5 | ||
≥10 | 27.9 | 24.1–31.9 | ||
Surgery | Yes | 34.5 | 31.2–38.0 | .48 |
No | 36.6 | 31.7–41.8 | ||
Chemotherapy | Yes | 47.2 | 41.1–53.5 | <.0001 |
No | 30.8 | 27.6–34.1 | ||
Radiation | Yes | 44.7 | 39.0–50.6 | <.001 |
No | 31.4 | 28.2–34.9 | ||
No. of comorbidities | 0 | 32.5 | 27.8–37.6 | .51 |
1 | 35.5 | 30.1–41.2 | ||
≥2 | 36.4 | 32.1–40.8 |
Abbreviations: 95% CI, 95% confidence interval; GED, General Educational Development test; Y, years.
Adjusted r2 = 0.16.
Predictive marginals adjust for all other variables in the model and are weighted to account for the complex sampling design.
Bold type indicates statistical significance.